Who invested in FLX Bio?
FLX Bio's investors include Google Ventures, The Column Group, Celgene, KPCB and Topspin.
United States · Series C startup
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$60Mraised across 1 round since 2017, from 1 source
Reported by VcnewsdailySEC filing: $30M sold, first sale Dec 2017
From the SEC filings it signed: 2 on the team.
On the board, as filediBeth SeidenbergDavid GoeddelLinda J. KozickWilliam J. Rieflin
FLX Bio's investors include Google Ventures, The Column Group, Celgene, KPCB and Topspin.
FLX Bio has raised $60M across 1 round since 2017.
FLX Bio's most recent round was a Series C of $60M in Dec 2017.
Its most recent round, $60M in Dec 2017, is also its largest on record.
FLX Bio's first round on record, in Dec 2017, was backed by Google Ventures, The Column Group and Celgene and 2 others.
FLX Bio's latest named round is a Series C, in Dec 2017.
FLX Bio is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.